466 related articles for article (PubMed ID: 1333651)
1. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
2. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro.
Nishiyama Y; Yamamoto N; Yamada Y; Daikoku T; Ichikawa Y; Takahashi K
J Antibiot (Tokyo); 1989 Dec; 42(12):1854-9. PubMed ID: 2559911
[TBL] [Abstract][Full Text] [Related]
3. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
Hu N; Shiota H
Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
[TBL] [Abstract][Full Text] [Related]
5. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
Koyano S; Suzutani T; Yoshida I; Azuma M
Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
Nitta K; Shiota H; Naito T; Mimura Y
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of various compounds against clinical strains of herpes simplex virus.
Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
[TBL] [Abstract][Full Text] [Related]
10. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Field H; McMillan A; Darby G
J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
[TBL] [Abstract][Full Text] [Related]
12. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G.
Daikoku T; Yamamoto N; Saito S; Kitagawa M; Shimada N; Nishiyama Y
Biochem Biophys Res Commun; 1991 Apr; 176(2):805-12. PubMed ID: 1851005
[TBL] [Abstract][Full Text] [Related]
14. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Schinazi RF; Nahmias AJ
Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
[TBL] [Abstract][Full Text] [Related]
15. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
16. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
17. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.
Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H
Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
Suzutani T; Machida H; Sakuma T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
Nugier F; Colin JN; Aymard M; Langlois M
J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
